Food, drugs, devices › Bayer HealthCare Pharmaceuticals Inc.
Drug recall: Medroxyprogesterone acetate, micronized (EP, USP) active pharmaceutical ingredient, Rx only, packaged in 6.0 kg drums (l
FDA enforcement event 65702 is a drug recall by Bayer HealthCare Pharmaceuticals Inc. of Morristown, NJ, initiated 13 Jun 2013 and classified Class III, with 1 product record.
FDA defines Class III as a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences. 26% of the 370 drug enforcement events initiated in 2013 carry the same class.
Status: Terminated, terminated 10 Feb 2014. Initiation: voluntary: firm initiated. Bayer HealthCare Pharmaceuticals Inc. has 10 enforcement events on this register, with a median of 1 product record per event.
Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.
Recalling firm
Bayer HealthCare Pharmaceuticals Inc., Morristown, NJ.
Reason for recall
"Failed Stability Specifications: Out of specification results for particle size were obtained at the 60 month test point."
Distribution
"NY, CA"
Product records
| Recall number | Product | Quantity | Class | Status | Report date |
|---|---|---|---|---|---|
| D-807-2013 | Medroxyprogesterone acetate, micronized (EP, USP) active pharmaceutical ingredient, Rx only, packaged in 6.0 kg drums (labeled as 6,000 kg), Bayer Schering Pharma AG, D-13342 Berlin | 194.62 kg | Class III | Terminated | 24 Jul 2013 |
Context
Other enforcement events for Bayer HealthCare Pharmaceuticals Inc.
All 10 events for Bayer HealthCare Pharmaceuticals Inc.
Questions and answers
Why was this drug recalled?
FDA's record gives the reason for recall as: "Failed Stability Specifications: Out of specification results for particle size were obtained at the 60 month test point."
What does Class III mean?
FDA classifies recalls by relative degree of health hazard. Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
Where was the product distributed?
FDA's distribution pattern field reads: "NY, CA"
Is the recall still ongoing?
FDA lists the status as Terminated; the termination date is 10 Feb 2014. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.
Where does this data come from?
openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.
Provenance
Source: openFDA drug enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.